评估二元分类器:扩展效率指数

IF 2.3 Q3 CLINICAL NEUROLOGY Neurodegenerative disease management Pub Date : 2022-02-04 DOI:10.1101/2022.02.02.22270139
A. Larner
{"title":"评估二元分类器:扩展效率指数","authors":"A. Larner","doi":"10.1101/2022.02.02.22270139","DOIUrl":null,"url":null,"abstract":"An efficiency index (EI) for the evaluation of binary classifiers was recently characterised, where EI is the ratio of classifier accuracy to inaccuracy. The purpose of this study was to further develop EI by substituting balanced accuracy and unbiased accuracy in place of accuracy, and their respective complements in place of inaccuracy, to construct balanced EI and unbiased EI measures. Additional investigations, using the dataset of a prospective pragmatic test accuracy study of a cognitive screening instrument, explored use of the log method to calculate confidence intervals for the various EI formulations; the dependence of EI formulations on prevalence; and comparison of EI formulations with analogous formulations based on the Identification Index (II), a previously described metric which is also based on accuracy and inaccuracy, where II is accuracy minus inaccuracy. EI formulations are shown to have advantages over II formulations, in particular their boundary values (0 and infinity) mean that negative values never occur, unlike the case for II, and the inflection point of 1 demarcates likelihood of correct versus incorrect classification.","PeriodicalId":19114,"journal":{"name":"Neurodegenerative disease management","volume":" ","pages":""},"PeriodicalIF":2.3000,"publicationDate":"2022-02-04","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"1","resultStr":"{\"title\":\"Evaluating binary classifiers: extending the Efficiency Index\",\"authors\":\"A. Larner\",\"doi\":\"10.1101/2022.02.02.22270139\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"An efficiency index (EI) for the evaluation of binary classifiers was recently characterised, where EI is the ratio of classifier accuracy to inaccuracy. The purpose of this study was to further develop EI by substituting balanced accuracy and unbiased accuracy in place of accuracy, and their respective complements in place of inaccuracy, to construct balanced EI and unbiased EI measures. Additional investigations, using the dataset of a prospective pragmatic test accuracy study of a cognitive screening instrument, explored use of the log method to calculate confidence intervals for the various EI formulations; the dependence of EI formulations on prevalence; and comparison of EI formulations with analogous formulations based on the Identification Index (II), a previously described metric which is also based on accuracy and inaccuracy, where II is accuracy minus inaccuracy. EI formulations are shown to have advantages over II formulations, in particular their boundary values (0 and infinity) mean that negative values never occur, unlike the case for II, and the inflection point of 1 demarcates likelihood of correct versus incorrect classification.\",\"PeriodicalId\":19114,\"journal\":{\"name\":\"Neurodegenerative disease management\",\"volume\":\" \",\"pages\":\"\"},\"PeriodicalIF\":2.3000,\"publicationDate\":\"2022-02-04\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"1\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Neurodegenerative disease management\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://doi.org/10.1101/2022.02.02.22270139\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"Q3\",\"JCRName\":\"CLINICAL NEUROLOGY\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Neurodegenerative disease management","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.1101/2022.02.02.22270139","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q3","JCRName":"CLINICAL NEUROLOGY","Score":null,"Total":0}
引用次数: 1

摘要

最近描述了用于评估二元分类器的效率指数(EI),其中EI是分类器准确性与不准确性的比率。本研究的目的是进一步发展EI,以平衡准确度和无偏准确度代替准确性,并以它们各自的互补代替不准确性,构建平衡EI和无偏EI测度。其他调查,使用认知筛选工具的前瞻性语用测试准确性研究数据集,探索使用对数方法计算各种EI公式的置信区间;EI公式对患病率的依赖性;以及EI公式与基于识别指数(II)的类似公式的比较,识别指数(II)是先前描述的度量,也是基于准确性和不准确性,其中II是准确性减去不准确性。EI公式被证明比II公式有优势,特别是它们的边界值(0和无穷大)意味着负值永远不会出现,不像II的情况,并且1的拐点划定了正确与不正确分类的可能性。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
查看原文
分享 分享
微信好友 朋友圈 QQ好友 复制链接
本刊更多论文
Evaluating binary classifiers: extending the Efficiency Index
An efficiency index (EI) for the evaluation of binary classifiers was recently characterised, where EI is the ratio of classifier accuracy to inaccuracy. The purpose of this study was to further develop EI by substituting balanced accuracy and unbiased accuracy in place of accuracy, and their respective complements in place of inaccuracy, to construct balanced EI and unbiased EI measures. Additional investigations, using the dataset of a prospective pragmatic test accuracy study of a cognitive screening instrument, explored use of the log method to calculate confidence intervals for the various EI formulations; the dependence of EI formulations on prevalence; and comparison of EI formulations with analogous formulations based on the Identification Index (II), a previously described metric which is also based on accuracy and inaccuracy, where II is accuracy minus inaccuracy. EI formulations are shown to have advantages over II formulations, in particular their boundary values (0 and infinity) mean that negative values never occur, unlike the case for II, and the inflection point of 1 demarcates likelihood of correct versus incorrect classification.
求助全文
通过发布文献求助,成功后即可免费获取论文全文。 去求助
来源期刊
CiteScore
4.30
自引率
0.00%
发文量
35
期刊最新文献
Economic evaluation of mHealth solutions in PD: where do we stand? Advances in the management of Alzheimer's disease. A plain language summary of a study exploring the experiences of people with relapsing-remitting multiple sclerosis: what symptoms and impacts of the disease matter most and how can they be evaluated better? Real world effectiveness, persistence, tolerability, and safety of ofatumumab in clinical practice. Friedreich ataxia: what can we learn from non-GAA repeat mutations?
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
已复制链接
已复制链接
快去分享给好友吧!
我知道了
×
扫码分享
扫码分享
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1